Compared with patients with the TT genotype, those with the ABCB1 rs1128503C allele had a higher risk of developing oral mucositis after receiving HDMTX (P = 0.054)), and had a longer duration of hospitalization for the HDMTX treatment (P = 0.006). This evidence concerns the gene ABCB1 and oral mucositis.